CClinicalTrials.gg
Status unknownNCT03275727INNOVBCUpdated Sep 8, 2017

A Guided Internet-delivered Individually-tailored ACT-influenced CBT Intervention to Improve Psychosocial Outcomes in Breast Cancer

A Phase 2/3 interventional study of iACT-BC in Breast Neoplasm, sponsored by Linkoeping University. Status unknown. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-09-08.

Sponsored by Linkoeping University · Phase 2/3, Interventional, and Supportive care

The sponsor has not verified this record recently (last verified Sep 2017), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Phase 2/3
Study type
Interventional
Enrollment
128
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Background: Internet-delivered interventions (IDI) can provide remarkable opportunities in addressing breast cancer (BC) survivors' unmet needs, as they present an effective strategy to improve care coordination and provide access to efficacious, cost-efficient and convenient survivorship care. Nevertheless, research focusing on this field and aiming at improving survivors´ psychosocial needs is scarce and its practical implementation is limited.

Objectives: This study aims at studying BC patients´ and healthcare providers' attitudes towards IDI; exploring BC patients´ unmet support needs and; determining the acceptability, feasibility, efficacy and cost-effectiveness of iACT-BC, a guided internet-delivered individually-tailored ACT-influenced cognitive behavioural intervention designed to improve psychosocial outcomes in BC survivors when compared to treatment as usual. The primary outcomes in this research are anxiety and depression. Secondary outcomes include psychological flexibility, fatigue, insomnia, Sexual dysfunction (SD) and Health Related Quality of Life.

Methods: A multimethod research design will be applied and two consecutive studies will be performed. Study 1 will explore participants´ attitudes towards IDI as well as, BC patients' psychosocial unmet needs by adopting an exploratory cross-sectional study design. Study 2 will investigate the effectiveness and cost-effectiveness of iACT-BC in BC survivors, by implementing a two-arm, parallel, open label, multicentre, waiting list randomized controlled trial.

Expected Results: It is anticipated that iACT-BC will show to be an effective and cost-effective program in improving anxiety, depression, psychological flexibility, fatigue, insomnia, SD and HRQoL in BC survivors, as opposing to a waiting list control under treatment as usual. The results of this research will be published in accordance with CONSORT 2010 and CONSORT-EHEALTH guidelines and should be available for publication in February 2020.

Read the detailed description

Background: Breast Cancer (BC) ranks as the most frequent and lethal cancer among women, in Portugal. However, advances in cancer detection and treatment contributed to a steady and significant increase in survival over the past years, and 5-year age-standardized relative survival is currently estimated to be 83,4%. This increase translates into a high and growing number of BC survivors, with a considerable proportion of these patients experiencing sequelae of treatment and late effects that can occur immediately to several years after primary treatment ends. Anxiety, depression, fear of recurrence, existential related issues, fatigue, pain, physical and cognitive impairment, tailored information needs, and sexual dysfunction have been reported as the most common unmet support care needs experienced by these women. The answer to these unmet support care needs relies, in part, on delivering comprehensive, highly coordinated, patient-centred care. However, operationalizing such care may prove difficult in a context of competing priorities and constrained health and social care budgets. In this context, connected health, particularly internet-delivered interventions, can provide remarkable opportunities in overcoming the aforementioned constraints, as presenting an effective and innovative healthcare delivery model capable of improving care coordination and providing access to efficacious, cost-efficient and convenient survivorship care. Nevertheless, research focusing on this field and aiming at improving survivors´ psychosocial needs is scarce and its practical implementation is limited.

Objectives: The objectives of this investigation are: studying BC patients´ and healthcare providers' attitudes towards internet-delivered interventions; exploring breast cancer patients´ unmet support care needs and; determining the acceptability, feasibility, effectiveness and cost-effectiveness of iACT-BC, a guided internet-delivered individually-tailored Acceptance and Commitment Therapy (ACT)-influenced cognitive behavioural intervention designed to improve psychosocial outcomes in BC survivors when compared to treatment as usual (TAU) in a waiting list control group (WLC). The primary outcomes in this research are anxiety and depression. Secondary outcomes include psychological flexibility, fatigue, insomnia, sexual dysfunction and Health Related Quality of Life (HRQoL).

Hypotheses: We hypothesize that participants in the intervention group will have improved anxiety, depression, psychological flexibility, fatigue, insomnia, sexual dysfunction and HRQoL, when compared to a WLC.

Methods: A multimethod research design will be applied and two consecutive studies will be performed: Study 1 - Population characterization study and Study 2 - Efficacy and cost-effectiveness study. Study 1 will explore participants´ attitudes towards internet-delivered interventions as well as, BC patients' psychosocial unmet support needs by adopting an exploratory cross-sectional study design. Study 2 will investigate the effectiveness and cost-effectiveness of iACT-BC in BC survivors, by implementing a two-arm, parallel, open label, multicentre, pragmatic, waiting list randomized controlled trial. A Pilot study, mirroring the conditions applied in Study 2 should be performed in order to evaluate the feasibility and acceptability of iACT-BC. Results from this Pilot study should be appraised and inform execution of Study 2

Ethical approval: This study will soon be submitted to evaluation by CNPD and local ethic committees. Authorization to run the study is expected to be received until January 2018.

Expected Results: It is anticipated that iACT-BC will show to be an effective and cost-effective program in improving psychosocial outcomes such as anxiety, depression, psychological flexibility, fatigue, insomnia, sexual dysfunction and HRQoL in BC survivors, as opposing to a WLC under TAU. The results of this research will be published in accordance with CONSORT 2010 and CONSORT-EHEALTH guidelines and should be available for publication in February 2020.

Keywords: Breast Cancer; Survivors; Internet intervention; Psychosocial intervention; Acceptance and Commitment Therapy (ACT); Randomized controlled trial protocol.

02

Conditions studied

  • Breast Neoplasm

Browse trials for

Keywords

  • Breast Cancer
  • Survivors
  • Internet intervention
  • Psychosocial intervention
  • Acceptance and Commitment Therapy (ACT)
  • Randomized controlled trial
03

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Signed written informed consent.
  • Age ≥ 18 years;
  • Ability to read and write in Portuguese.
  • History of histologically or cytologically confirmed breast cancer with no evidence of metastatic disease.
  • An interval ≥ 6 month from primary adjuvant treatment completion (surgery, chemotherapy and/or radiotherapy), except for hormonal therapy.
  • Clinically significant symptoms of at least one of the following conditions: anxiety, depression, fatigue, insomnia and/or sexual dysfunction.
  • Ongoing regular psychoactive medication only accepted if dosage has been stable during the last 3 months.
  • Daily access to the Internet by computer and/or smartphone.
  • Ability to use a computer and/or smartphone and the internet.
  • No participation on any other interventional study or clinical trial.

Exclusion criteria

Exclusion Criteria:

  • Age ≤ 18 years;
  • Inability to co-operate and give informed consent.
  • Breast cancer not histologically or cytologically confirmed.
  • History of other malignancy within the last 5 years.
  • Metastasized breast cancer.
  • Current severe, uncontrolled systemic disease or mental disorder.
  • Absence of clinically significant symptoms.
  • Parallel ongoing psychological treatment.
  • Ongoing regular psychoactive medication if dosage has been changed during the last 3 months.
  • No access to the internet.
  • Inability to use a computer and/or smartphone and the internet.
  • Parallel ongoing participation in other interventional study or clinical trial.
  • Assessment by the investigator to be unable or unwilling to comply with the requirements of the protocol.
04

Study design

Phase
Phase 2 / Phase 3
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
128 participants (estimated)

Study arms

  • Experimental
    A - iACT-BC experimental group

    Behavioral: iACT-BC

  • Other
    B - Waiting list control group

    Behavioral: iACT-BC

Interventions

  • BehavioraliACT-BC

    A Guided INternet-delivered Individually-tailored ACT-influenced Cognitive Behavioural INtervention to ImprOVe Psychosocial Outcomes in Breast Cancer Survivors

05

What researchers measure

Primary outcomes

  1. Depression

    Patient Health Questionnaire (PHQ-9)

    Time frame: Change from baseline to post-intervention (10 weeks after enrollment), Follow-ups at 3, 6 and 12 months

  2. Anxiety

    Generalized Anxiety Disorder Scale (GAD-7)

    Time frame: Change from baseline to post-intervention (10 weeks after enrollment), Follow-ups at 3, 6 and 12 months

Secondary outcomes

  1. Psychological flexibility

    Cancer Acceptance and Action Questionnaire (Cancer AAQ)

    Time frame: Change from baseline to post-intervention (10 weeks after enrollment), Follow-ups at 3, 6 and 12 months

  2. Fatigue

    Brief Fatigue Inventory (BFI)

    Time frame: Change from baseline to post-intervention (10 weeks after enrollment), Follow-ups at 3, 6 and 12 months

  3. Insomnia

    Insomnia Severity Index (ISI)

    Time frame: Change from baseline to post-intervention (10 weeks after enrollment), Follow-ups at 3, 6 and 12 months

  4. Sexual dysfunction

    Female Sexual Function Index (FSFI)

    Time frame: Change from baseline to post-intervention (10 weeks after enrollment), Follow-ups at 3, 6 and 12 months

  5. Health related quality of life - generic measure

    EORTC QLQC30

    Time frame: Change from baseline to post-intervention (10 weeks after enrollment), Follow-ups at 3, 6 and 12 months

  6. Health related quality of life - breast cancer specific measure

    EORTC QLQBR23

    Time frame: Change from baseline to post-intervention (10 weeks after enrollment), Follow-ups at 3, 6 and 12 months

Other outcomes

  1. Participants' attitudes towards internet interventions

    Attitudes towards internet interventions survey (ATTIS)

    Time frame: Change from baseline to post-intervention (10 weeks after enrollment), Follow-ups at 3, 6 and 12 months

  2. Breast cancer patients' unmet support needs

    Supportive Care Needs Survey Questionnaire (SCNS-SF34)

    Time frame: Change from baseline to post-intervention (10 weeks after enrollment), Follow-ups at 3, 6 and 12 months

  3. Intervention cost-effectiveness

    Questionnaire on Medical consumption and Productivity losses associated with Psychiatric Illness (TIC-P)

    Time frame: Change from baseline to post-intervention (10 weeks after enrollment), Follow-ups at 3, 6 and 12 months

  4. Intervention cost-utility

    EuroQol EQ-5D-5L

    Time frame: Change from baseline to post-intervention (10 weeks after enrollment), Follow-ups at 3, 6 and 12 months

06

Study locations

No study locations are listed for this record.

07

References and documents

Publications

  • Mendes-Santos C, Weiderpass E, Santana R, Andersson G. A guided internet-delivered individually-tailored ACT-influenced cognitive behavioural intervention to improve psychosocial outcomes in breast cancer survivors (iNNOVBC): Study protocol. Internet Interv. 2019 Feb 10;17:100236. doi: 10.1016/j.invent.2019.01.004. eCollection 2019 Sep. PubMed 30949435 ↗

Individual participant data

Plan to share: No

08

Registry details

Key details

Study ID
NCT03275727
Lead sponsor
Linkoeping University
Collaborators
Universidade Nova de Lisboa
Responsible party
Gerhard Andersson (Professor, Linkoeping University) — Principal investigator
First posted
Sep 8, 2017
Start date
Feb 2018 (estimated)
Primary completion
Dec 2019 (estimated)
Completion
Dec 2019 (estimated)
Last update
Sep 8, 2017

Study contacts

Cristina M Santos, MsC
Contact
cristina.mendes.santos@liu.se
+351917890798
Gerhard Andersson, PhD
Contact
gerhard.andersson@liu.se

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion